HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Constantine S Mitsiades Selected Research

Telomerase (Telomerase Reverse Transcriptase)

3/2024Retraction: Cytokines Modulate Telomerase Activity in a Human Multiple Myeloma Cell Line.
1/2003Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein.
1/2002Cytokines modulate telomerase activity in a human multiple myeloma cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Constantine S Mitsiades Research Topics

Disease

83Multiple Myeloma
04/2024 - 01/2002
75Neoplasms (Cancer)
02/2024 - 06/2002
8Hematologic Neoplasms (Hematological Malignancy)
11/2009 - 03/2004
8Thyroid Neoplasms (Thyroid Cancer)
12/2007 - 08/2002
6Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2004
5Retinoblastoma (Glioblastoma, Retinal)
09/2009 - 12/2002
4Lymphoma (Lymphomas)
11/2023 - 01/2005
4Carcinoma (Carcinomatosis)
12/2009 - 09/2006
3Breast Neoplasms (Breast Cancer)
01/2021 - 02/2011
3Leukemia
01/2021 - 04/2010
3Fatigue
01/2012 - 06/2010
3Medullary Carcinoma
12/2009 - 05/2005
3Waldenstrom Macroglobulinemia (Macroglobulinemia)
05/2009 - 04/2003
2Genetic Translocation (Chromosomal Translocation)
04/2024 - 12/2005
2Paraproteinemias (Monoclonal Gammopathy)
01/2024 - 11/2004
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2023 - 07/2012
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2021 - 10/2006
2Bone Diseases (Bone Disease)
01/2021 - 01/2012
2Carcinogenesis
10/2018 - 02/2011
2Hypoxia (Hypoxemia)
01/2018 - 11/2003
2Thrombocytopenia (Thrombopenia)
07/2012 - 01/2012
2Diabetic Retinopathy (Retinopathy, Diabetic)
10/2009 - 08/2004
2Leukostasis
10/2009 - 08/2004
2Anaplastic Thyroid Carcinoma
10/2006 - 10/2003
2Neoplasm Metastasis (Metastasis)
09/2006 - 07/2004
2Chromosomal Instability (Chromosome Stability)
01/2003 - 01/2002
1Hypersensitivity (Allergy)
04/2024

Drug/Important Bio-Agent (IBA)

30Bortezomib (Velcade)FDA Link
01/2021 - 09/2002
20Proteasome InhibitorsIBA
01/2024 - 06/2002
15Proteins (Proteins, Gene)FDA Link
12/2023 - 04/2003
15Dexamethasone (Maxidex)FDA LinkGeneric
03/2014 - 03/2002
14Lenalidomide (CC 5013)FDA Link
01/2021 - 06/2004
13Thalidomide (Thalomid)FDA Link
01/2014 - 06/2002
11NF-kappa B (NF-kB)IBA
04/2010 - 06/2002
7Phosphotransferases (Kinase)IBA
11/2023 - 03/2004
7Insulin-Like Growth Factor I (IGF-1)IBA
10/2006 - 08/2002
6LigandsIBA
01/2018 - 03/2002
6Immunomodulating AgentsIBA
06/2015 - 04/2009
6VorinostatFDA Link
07/2013 - 04/2003
6Histone Deacetylase InhibitorsIBA
07/2013 - 04/2003
6Antineoplastic Agents (Antineoplastics)IBA
11/2012 - 02/2006
5CytokinesIBA
03/2024 - 01/2002
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2003
5Proteasome Endopeptidase Complex (Proteasome)IBA
11/2017 - 10/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2012 - 03/2002
5Doxorubicin (Adriamycin)FDA LinkGeneric
04/2012 - 03/2003
4Death Domain ReceptorsIBA
12/2023 - 01/2005
4Transcription Factors (Transcription Factor)IBA
01/2016 - 06/2002
4GlucocorticoidsIBA
07/2012 - 01/2005
4tanespimycin (17AAG)IBA
02/2011 - 02/2006
4Neutralizing AntibodiesIBA
10/2009 - 03/2004
4AndrogensIBA
09/2006 - 03/2004
3Telomerase (Telomerase Reverse Transcriptase)IBA
03/2024 - 01/2002
3Histones (Histone)IBA
02/2024 - 11/2009
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2021 - 06/2006
3Histone Deacetylases (Histone Deacetylase)IBA
07/2013 - 01/2004
3Melphalan (Alkeran)FDA LinkGeneric
07/2012 - 03/2003
3Heat-Shock Proteins (Heat-Shock Protein)IBA
02/2011 - 10/2002
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2009 - 05/2005
3Complementary DNA (cDNA)IBA
10/2009 - 05/2005
3Caspase 8 (Caspase-8)IBA
06/2006 - 01/2005
3Transcription Factor AP-1 (Transcription Factor AP 1)IBA
06/2006 - 11/2003
3geldanamycinIBA
02/2006 - 04/2003
3Interleukin-6 (Interleukin 6)IBA
08/2005 - 01/2002
3Insulin-Like PeptidesIBA
03/2004 - 01/2002
2dacetuzumabIBA
03/2024 - 04/2004
2Cyclophilins (Cyclophilin)IBA
01/2024 - 06/2015
2venetoclaxIBA
11/2023 - 01/2021
2AntibodiesIBA
01/2022 - 08/2005
2RNA (Ribonucleic Acid)IBA
01/2021 - 03/2007
2Hormones (Hormone)IBA
01/2021 - 11/2012
2PanobinostatIBA
01/2021 - 07/2013
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2021
2Oncogene Proteins (Oncogene Protein)IBA
01/2021 - 09/2011
2ixazomibIBA
01/2021 - 10/2018
2Estrogen ReceptorsIBA
07/2014 - 02/2006
2Caspase 3 (Caspase-3)IBA
10/2013 - 12/2009
2LuciferasesIBA
10/2013 - 04/2010
2Peptides (Polypeptides)IBA
09/2012 - 03/2004
2Diphosphonates (Bisphosphonates)IBA
01/2012 - 09/2006
2Zoledronic Acid (Zometa)FDA Link
01/2012 - 09/2006
2DepsipeptidesIBA
06/2010 - 07/2008
2plitidepsin (aplidine)IBA
06/2010 - 07/2008
2Imatinib Mesylate (Gleevec)FDA Link
04/2010 - 10/2003
2Alkylating AgentsIBA
07/2008 - 07/2007
2CaspasesIBA
10/2007 - 05/2005
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
09/2006 - 07/2004
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2005 - 03/2004
2Monoclonal AntibodiesIBA
06/2005 - 01/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2004 - 11/2003
1Histone MethyltransferasesIBA
04/2024
1CreatineIBA
04/2024
1Phosphocreatine (Neoton)IBA
04/2024
1Phosphates (Orthophosphate)IBA
04/2024
1Glycoproteins (Glycoprotein)IBA
12/2023
1Interferon Type IIBA
12/2023

Therapy/Procedure

40Therapeutics
12/2023 - 04/2003
12Drug Therapy (Chemotherapy)
01/2021 - 03/2002
4Immunotherapy
01/2022 - 10/2013
2Stem Cell Transplantation
06/2015 - 02/2009